363 related articles for article (PubMed ID: 11912139)
1. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
2. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines.
Gilhooly EM; Rose DP
Int J Oncol; 1999 Aug; 15(2):267-70. PubMed ID: 10402236
[TBL] [Abstract][Full Text] [Related]
3. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
[TBL] [Abstract][Full Text] [Related]
4. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker ON; Dannenberg AJ; Yang EK; Zhang F; Teng L; Daly JM; Soslow RA; Masferrer JL; Woerner BM; Koki AT; Fahey TJ
Cancer Res; 1999 Mar; 59(5):987-90. PubMed ID: 10070951
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan G; Boyle JO; Yang EK; Zhang F; Sacks PG; Shah JP; Edelstein D; Soslow RA; Koki AT; Woerner BM; Masferrer JL; Dannenberg AJ
Cancer Res; 1999 Mar; 59(5):991-4. PubMed ID: 10070952
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
[TBL] [Abstract][Full Text] [Related]
9. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Umbricht CB; Sherman ME; Dome J; Carey LA; Marks J; Kim N; Sukumar S
Oncogene; 1999 Jun; 18(22):3407-14. PubMed ID: 10362362
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclooxygenase-2 pathway by HER2 receptor.
Vadlamudi R; Mandal M; Adam L; Steinbach G; Mendelsohn J; Kumar R
Oncogene; 1999 Jan; 18(2):305-14. PubMed ID: 9927187
[TBL] [Abstract][Full Text] [Related]
12. The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.
Liu E; Thor A; He M; Barcos M; Ljung BM; Benz C
Oncogene; 1992 May; 7(5):1027-32. PubMed ID: 1349163
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines.
Liu XH; Rose DP
Cancer Res; 1996 Nov; 56(22):5125-7. PubMed ID: 8912844
[TBL] [Abstract][Full Text] [Related]
14. Expression of 15-lipoxygenase-1 in human colorectal cancer.
Ikawa H; Kamitani H; Calvo BF; Foley JF; Eling TE
Cancer Res; 1999 Jan; 59(2):360-6. PubMed ID: 9927047
[TBL] [Abstract][Full Text] [Related]
15. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
17. Comparison of features of human breast cancer cell lines and their corresponding tumors.
Wistuba II; Behrens C; Milchgrub S; Syed S; Ahmadian M; Virmani AK; Kurvari V; Cunningham TH; Ashfaq R; Minna JD; Gazdar AF
Clin Cancer Res; 1998 Dec; 4(12):2931-8. PubMed ID: 9865903
[TBL] [Abstract][Full Text] [Related]
18. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 in human gastric carcinoma.
Ristimäki A; Honkanen N; Jänkälä H; Sipponen P; Härkönen M
Cancer Res; 1997 Apr; 57(7):1276-80. PubMed ID: 9102213
[TBL] [Abstract][Full Text] [Related]
20. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]